Biota starts testing common cold drug
Drug developer Biota Holdings says clinical testing has begun on a potential drug to prevent and treat the common cold. Biota said the so-called BTA-798 drug, targeting Human Rhinovirus (HRV), would
Drug developer Biota Holdings says clinical testing has begun on a potential drug to prevent and treat the common cold. Biota said the so-called BTA-798 drug, targeting Human Rhinovirus (HRV), would